BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15901536)

  • 1. Intermediates in P450 catalysis.
    Poulos TL
    Philos Trans A Math Phys Eng Sci; 2005 Apr; 363(1829):793-806; discussion 1035-40. PubMed ID: 15901536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density functional theory applied to a difference in pathways taken by the enzymes cytochrome P450 and superoxide reductase: spin States of ferric hydroperoxo intermediates and hydrogen bonds from water.
    Surawatanawong P; Tye JW; Hall MB
    Inorg Chem; 2010 Jan; 49(1):188-98. PubMed ID: 19968237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundamental differences of substrate hydroxylation by high-valent iron(IV)-oxo models of cytochrome P450.
    Tahsini L; Bagherzadeh M; Nam W; de Visser SP
    Inorg Chem; 2009 Jul; 48(14):6661-9. PubMed ID: 19469505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propene activation by the oxo-iron active species of taurine/alpha-ketoglutarate dioxygenase (TauD) enzyme. How does the catalysis compare to heme-enzymes?
    de Visser SP
    J Am Chem Soc; 2006 Aug; 128(30):9813-24. PubMed ID: 16866538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen activation and redox partner binding in cytochromes P450.
    Poulos TL; Madrona Y
    Biotechnol Appl Biochem; 2013; 60(1):128-33. PubMed ID: 23587000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
    Lefèvre-Groboillot D; Frapart Y; Desbois A; Zimmermann JL; Boucher JL; Gorren AC; Mayer B; Stuehr DJ; Mansuy D
    Biochemistry; 2003 Apr; 42(13):3858-67. PubMed ID: 12667076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.
    Hlavica P
    Eur J Biochem; 2004 Nov; 271(22):4335-60. PubMed ID: 15560776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms.
    Perret A; Pompon D
    Biochemistry; 1998 Aug; 37(33):11412-24. PubMed ID: 9708976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton assisted oxygen-oxygen bond splitting in cytochrome p450.
    Groenhof AR; Ehlers AW; Lammertsma K
    J Am Chem Soc; 2007 May; 129(19):6204-9. PubMed ID: 17441718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopic and mechanistic studies on oxidation reactions catalyzed by the functional Model SR complex for cytochrome P450: influence of oxidant, substrate, and solvent.
    Hessenauer-Ilicheva N; Franke A; Wolak M; Higuchi T; van Eldik R
    Chemistry; 2009 Nov; 15(45):12447-59. PubMed ID: 19806618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the axial ligand on substrate sulfoxidation mediated by iron(IV)-oxo porphyrin cation radical oxidants.
    Kumar D; Sastry GN; de Visser SP
    Chemistry; 2011 May; 17(22):6196-205. PubMed ID: 21469227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic investigations of intermediates in the reaction of cytochrome P450(BM3)-F87G with surrogate oxygen atom donors.
    Raner GM; Thompson JI; Haddy A; Tangham V; Bynum N; Ramachandra Reddy G; Ballou DP; Dawson JH
    J Inorg Biochem; 2006 Dec; 100(12):2045-53. PubMed ID: 17083977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
    Fasan R; Chen MM; Crook NC; Arnold FH
    Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of substrate on the spectral properties of oxyferrous wild-type and T252A cytochrome P450-CAM.
    Sono M; Perera R; Jin S; Makris TM; Sligar SG; Bryson TA; Dawson JH
    Arch Biochem Biophys; 2005 Apr; 436(1):40-9. PubMed ID: 15752707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
    Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
    J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicking biological electron transfer and oxygen activation involving iron and copper proteins: a bio(in)organic supramolecular approach.
    Feiters MC
    Met Ions Biol Syst; 2001; 38():461-655. PubMed ID: 11219019
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantum chemical calculations of the NHA bound nitric oxide synthase active site: O2 binding and implications for the catalytic mechanism.
    Cho KB; Gauld JW
    J Am Chem Soc; 2004 Aug; 126(33):10267-70. PubMed ID: 15315438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does the axial ligand of cytochrome P450 biomimetics influence the regioselectivity of aliphatic versus aromatic hydroxylation?
    de Visser SP; Tahsini L; Nam W
    Chemistry; 2009; 15(22):5577-87. PubMed ID: 19347895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Density functional theory (DFT) and combined quantum mechanical/molecular mechanics (QM/MM) studies on the oxygen activation step in nitric oxide synthase enzymes.
    de Visser SP
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):373-7. PubMed ID: 19290865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.